Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004197675 | SCV003687332 | uncertain significance | not specified | 2022-09-26 | criteria provided, single submitter | clinical testing | The c.1696C>T (p.H566Y) alteration is located in exon 15 (coding exon 15) of the TREH gene. This alteration results from a C to T substitution at nucleotide position 1696, causing the histidine (H) at amino acid position 566 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003954014 | SCV004768208 | likely benign | TREH-related disorder | 2020-02-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |